Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Antisense patent trial wraps up

Nature Medicine volume 1, page 389 (1995)Cite this article

Two biotechnology companies — and a host of other companies and research institutions — are awaiting a federal ruling on antisense technology patent rights.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Washington, DC

    Fintan R. Steele

Authors
  1. Fintan R. Steele
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steele, F. Antisense patent trial wraps up. Nat Med 1, 389 (1995). https://doi.org/10.1038/nm0595-389a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0595-389a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing